| Company | Lead Banks | Tranche | Price | Purpose | Update |
| Gundle/SLT Environmental | UBS | $40 million revolver | L+275 | LBO | Rated B3 by Moody's |
| $25 million term loan | L+300 | ||||
| Leiner Health Products | UBS | $50 million revolver | L+275 | Refi | Rated B1 by Moody's |
| Morgan Stanley | $240 million B loan | L+300 | |||
| CSFB | |||||
| MAAX | Goldman Sachs | C$50 million revolver | LBO | B loan launched May 10 | |
| Royal Bank of Canada | C$130 million A loan | Rated B+ by S&P | |||
| Merrill Lynch | $110 million B loan | ||||
| NEP Broadcasting | Wachovia | $20 million revolver | L+300 | LBO | Launched May 11 |
| $145 millin B loan | L+350 | Price talk has emerged | |||
| $45 million second-lien term loan | L+650 | ||||
| Roller Bearing | GE Capital | $60 million revolver | L+300 | Refi | In syndication |
| $115 million B loan | L+325 | ||||
| $45 million second-lien term loan | L+750 | ||||
| Sterigenics International | UBS | $35 million revolver | L+300 | LBO | First lien rated B+, second lien rated B- by S&P |
| $170.5 million term loan | L+300 | First lien rated B2, second lien rated B3 by Moody's | |||
| $35 million second-lien facility | L+625 | ||||
| Sunny Delight | UBS | $50 million revolver | L+250 | LBO | In syndication |
| $150 million first-lien term loan | L+250 | ||||
| $100 million European term loan | L+300 | ||||
| $35 million second-lien term loan | L+550 | ||||
| TransFirst Holdings | Merrill Lynch Capital | $35 million revolver | L+350 | Refi | Syndication is oversubscribed |
| GE Capital | $50 million A loan | L+350 | Some of the A may move into the second lien, a banker said | ||
| $105 million B loan | L+400 | ||||
| $75 million junior C loan | L+650 | ||||
| WellCare Health Plans | CSFB | $50 million revolver | L+375 | Acqui | In syndication |
| Morgan Stanley | $160 million B loan | L+400 | |||
| The Primary Roundup is a compilation of deals previously reported by LMW, as of Thurs, May 13 |